29.12.2021 Views

Diagnostic ultrasound ( PDFDrive )

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

1624 PART V Pediatric Sonography

46. Wang L, He W, Wang HS, et al. Comparison of transcranial color-coded

real-time sonography and contrast enhanced color-coded sonography for

detection and characterization of intracranial arteriovenous malformations.

J Ultrasound Med. 2014;33:273-280.

47. Griewing B, Schminke U, Motsch L, et al. Transcranial duplex sonography

of middle cerebral artery stenosis: a comparison of colour-coding

techniques—frequency- or power-based Doppler and contrast enhancement.

Neuroradiology. 1998;40(8):490-495.

48. Droste DW, Llull JB, Pezzoli C, et al. SonoVue (BR1), a new long-acting

echocontrast agent, improves transcranial colour-coded duplex ultrasonic

imaging. Cerebrovasc Dis. 2002;14(1):27-32.

49. Droste DW, Jurgens R, Weber S, et al. Beneit of echocontrast-enhanced

transcranial color-coded duplex ultrasound in the assessment of intracranial

collateral pathways. Stroke. 2000;31(4):920-923.

50. Postert T, Braun B, Pfundtner N, et al. Echo contrast-enhanced threedimensional

power Doppler of intracranial arteries. Ultrasound Med Biol.

1998;24(7):953-962.

51. Gerriets T, Seidel G, Fiss I, et al. Contrast-enhanced transcranial color-coded

duplex sonography: eiciency and validity. Neurology. 1999;52(6):

1133-1137.

52. Seibert JJ. Doppler evaluation of cerebral circulation. In: Dieckmann RA,

Fiser DHB, Selbst SM, editors. Illustrated textbook of pediatric emergency

and critical care procedures. St. Louis: Mosby–Year Book; 1997.

53. hust S, Burke C, Siddiqui A. Neuroimaging indings in sickle cell disease.

Br J Radiol. 2014;87(1040):20130699.

54. DeBaun M, Armstrong D, McKinstry R, et al. Silent cerebral infarcts: a

review on a prevalent and progressive cause of neurologic injury in sickle

cell anemia. Blood. 2012;119(20):4587-4596.

55. Kato G, Hebbel R, Steinberg M, et al. Vasculopathy in sickle cell disease.

Am J Hematol. 2009;84(9):618-625.

56. Jordan L, Casella J, DeBaun M. Prospects for primary stroke prevention

in children with sickle cell anemia. Br J Haematol. 2012;157(1):14-25.

57. Colombatti R, Meneghetti G, Ermani M, et al. Primary stroke

prevention for sickle cell disease in north-east Italy: the role of ethnic issues

in establishing a transcranial Doppler screening program. Ital J Pediatr.

2009;35:15.

58. Bader-Meunier B, Verlhac S, Elmaleh-Berges M, et al. Efect of transfusion

therapy on cerebral vasculopathy in children with sickle-cell anemia.

Hematologica. 2009;94(1):123-126.

59. DeBaun M, Armstrong D, McKinstry R, et al. Controlled trial of transfusions

for silent cerebral infarcts in sickle cell anemia. N Engl J Med. 2014;371(8):

699-710.

60. Kwiatkowski J, Ym E, Miller S, et al. Efect of transfusion therapy on

transcranial Doppler ultrasonography velocities in children with sickle cell

disease. Pediatr Blood Cancer. 2011;56(5):777-782.

61. Nafaa L, Tandon Y, Irani N. Transcranial Doppler screening in sickle cell

disease: the implications of using peak systolic criteria. World J Radiol.

2015;7(2):52-56.

62. Walters MC, Patience M, Leisenring W, et al. Bone marrow transplantation

for sickle cell disease. N Engl J Med. 1996;335(6):369-376.

63. Verlhac S, Bernaudin F, Tortrat D, et al. Detection of cerebrovascular disease

in patients with sickle cell disease using transcranial Doppler sonography:

correlation with MRI, MRA and conventional angiography. Pediatr Radiol.

1995;25(Suppl. 1):S14-S19.

64. Kwiatkowski J, Zimmerman R, Pollock A, et al. Silent infarcts in young

children with sickle cell disease. Br J Haematol. 2009;146(3):300-

305.

65. Adams RJ, Aaslid R, el Gammal T, et al. Detection of cerebral vasculopathy

in sickle cell disease using transcranial Doppler ultrasonography and magnetic

resonance imaging. Case report. Stroke. 1988;19(4):518-520.

66. Seibert JJ, Miller SF, Kirby RS, et al. Cerebrovascular disease in symptomatic

and asymptomatic patients with sickle cell anemia: screening with duplex

transcranial Doppler US—correlation with MR imaging and MR angiography.

Radiology. 1993;189(2):457-466.

67. Seibert JJ, Glasier CM, Kirby RS, et al. Transcranial Doppler, MRA, and

MRI as a screening examination for cerebrovascular disease in patients

with sickle cell anemia: an 8-year study. Pediatr Radiol. 1998;28(3):

138-142.

68. Siegel MJ, Luker GD, Glauser TA, DeBaun MR. Cerebral infarction in sickle

cell disease: transcranial Doppler US versus neurologic examination.

Radiology. 1995;197(1):191-194.

69. Kogutt MS, Goldwag SS, Gupta KL, et al. Correlation of transcranial Doppler

ultrasonography with MRI and MRA in the evaluation of sickle cell disease

patients with prior stroke. Pediatr Radiol. 1994;24(3):204-206.

70. Adams RJ, Nichols FT, Figueroa R, et al. Transcranial Doppler correlation

with cerebral angiography in sickle cell disease. Stroke. 1992;23(8):

1073-1077.

71. Brambilla D, Miller S, Adams R. Intra-individual variation in blood low

velocities in cerebral arteries of children with sickle cell disease. Pediatr

Blood Cancer. 2007;49(3):318-322.

72. Nichols FT, Jones AM, Adams RJ. Stroke prevention in sickle cell disease

(STOP) study guidelines for transcranial Doppler testing. J Neuroimaging.

2001;11(4):354-362.

73. Adams RJ, McKie VC, Hsu L, et al. Prevention of a irst stroke by transfusions

in children with sickle cell anemia and abnormal results on transcranial

Doppler ultrasonography. N Engl J Med. 1998;339(1):5-11.

74. Adams RJ, McKie VC, Brambilla D, et al. Stroke prevention trial in sickle

cell anemia. Control Clin Trials. 1998;19(1):110-129.

75. Pegelow CH, Wang W, Granger S, et al. Silent infarcts in children with

sickle cell anemia and abnormal cerebral artery velocity. Arch Neurol.

2001;58:2017-2021.

76. Lee M, Piomelli S, Granger S, et al. Stroke Prevention Trial in Sickle Cell

Anemia (STOP): extended follow-up and inal results. Blood. 2006;108(3):

847-852.

77. Jones A, Granger S, Brambilla D, et al. Can peak systolic velocities be used

for prediction of stroke in sickle cell anemia? Pediatr Radiol. 2005;35(1):

66-72.

78. Verlhac S, Balandra S, Cussenot I, et al. Extracranial carotid arteriopathy

in strokefree children with sickle cell anemia: detection by submandibular

Doppler sonography. Pediatr Radiol. 2014;44(5):587-596.

79. Leite A, de Oliveira R, de Moura P, et al. Abnormal transcranial Doppler

ultrasonography in children with sickle cell disease. Rev Bras Hematol

Hemoter. 2012;34(4):307-310.

80. McGann P, Nero A, Ware R. Current management of sickle cell anemia.

Cold Spring Harb Perspect Med. 2013;3(8):a011817.

81. Enningful-Eghan H, Moore R, Ichord R, et al. Transcranial Doppler screening

and prophylactic transfusion program is efective in preventing overt stroke

in children with sickle cell disease. J Padiatr. 2010;157(3):479-484.

82. Wang WC, Gallagher DM, Pegelow CH, et al. Multicenter comparison of

magnetic resonance imaging and transcranial Doppler ultrasonography in

the evaluation of the central nervous system in children with sickle cell

disease. J Pediatr Hematol Oncol. 2000;22(4):335-339.

83. Buchanan I, James-Herry A, Osunkwo I. he other side of abnormal: a

case series of low transcranial Doppler velocities associated with stroke in

children with sickle cell disease. J Pediatr Hematol Oncol.

2013;35(7):543-546.

84. Kwiatkowski JL, Granger S, Brambilla DJ, et al. Elevated blood low

velocity in the anterior cerebral artery and stroke risk in sickle cell disease:

extended analysis from the STOP trial. Br J Haematol. 2006;134(3):

333-339.

85. Lebensburger J, Miller S, Howard T, et al. Inluence of severity of anemia

on clinical indings in infants with sickle cell anemia: analyses from the

BABY HUG study. Pediatr Blood Cancer. 2012;59(4):675-678.

86. Pavlakis S, Rees R, Huang X, et al. Transcranial Doppler ultrasonography

(TCD) in infants with sickle cell anemia: baseline data from the BABY

HUG trial. Pediatr Blood Cancer. 2010;54(2):256-259.

87. Shahripour R, Mortazavi M, Barlinn K, et al. Can STOP trial velocity criteria

be applied to Iranian children with sickle cell disease? J Stroke. 2014;

16(2):97-101.

88. Padayachee ST, homas N, Arnold AJ, Inusa B. Problems with implementing

a standardised transcranial Doppler screening programme: impact of

instrumentation variation on STOP classiication. Pediatr Radiol.

2012;42(4):470-474.

89. Hankins JS, Fortner GL, McCarville MB, et al. he natural history of

conditional transcranial Doppler low velocities in children with sickle cell

anaemia. Br J Haematol. 2008;142(1):94-99.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!